Innovative Prostate Screening Device Developed by Student to Enhance Diagnostic Accuracy

A Loughborough University student's innovative device offers a non-invasive, accurate approach to prostate screening, enhancing early detection and patient comfort. Discover how PRO check leverages laser mapping and AI technology for better diagnosis.
A talented student from Loughborough University has created a groundbreaking medical device aimed at transforming prostate health assessment. Named "PRO check," this device offers a non-invasive, objective alternative to the traditional digital rectal examination (DRE), which has long been a standard but somewhat invasive method for evaluating prostate conditions.
Devon Tyso, a Product Design and Technology student, designed PRO check to address the limitations of current prostate examinations. The conventional DRE relies heavily on a clinician’s subjective judgment, which can lead to inconsistencies and discomfort for patients. Recognizing these challenges, Devon drew inspiration from NASA's surface mapping techniques, which use laser grids and satellite imagery to analyze asteroid surfaces. He adapted this principle into a handheld probe capable of detailed prostate surface analysis.
The device is inserted into the rectum after covering it with a condom to maintain hygiene. Once in place, it inflates the condom to apply controlled pressure against the prostate surface. A laser grid projected onto the condom captures images as the prostate compresses, with stereoscopic cameras tracking the intersection points of the laser lines. This data is processed to create 3D surface models, revealing the prostate’s shape and density.
Additionally, PRO check can measure prostate volume and generate a compressibility-pressure graph—which is a novel metric—that may help identify abnormalities such as stiffness or irregularities linked to potential health issues, including cancer. The device integrates AI for real-time analysis, enabling clinicians to view instant 3D visualizations during examinations, with all data stored in patient records for ongoing monitoring.
Devon’s innovation was driven by personal experience—his grandfather’s prostate cancer diagnosis—and his curiosity about applying advanced surface mapping techniques in medicine. His prototypes, built for testing with silicone prostate models, demonstrated the device’s capability to produce detailed surface images under various simulated conditions.
Set to showcase at the upcoming New Designers event in London, Devon aims to collaborate with healthcare professionals to bring PRO check to clinical use. His ultimate goal is to see this technology adopted in UK GP surgeries, making prostate screening more comfortable, accessible, and precise for men across the country.
For further information, visit the Degree Show website.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Recall of Over 110,000 Rich's Ice Cream Bars Due to Listeria Concerns
Over 110,000 Rich's ice cream bars are recalled due to potential Listeria contamination, posing health risks. Consumers should check their products and avoid consumption.
The Impact of the Republican Megabill on Americans' Healthcare Costs
A new Republican proposal aims to cut healthcare funding by $1 trillion, potentially increasing the number of uninsured Americans and straining healthcare providers, especially in rural areas.
Discovery of PROX1 Gene as an Early Indicator of Aggressive Prostate Cancer
A groundbreaking study by the University of Michigan has identified the PROX1 gene as an early driver of aggressive, treatment-resistant prostate cancer. Targeting PROX1 with existing HDAC inhibitors may offer new therapeutic options for advanced prostate cancer patients.
New Study Confirms Medicaid Expansion Saves Lives in Low-Income Populations
A large-scale study finds Medicaid expansion has significantly decreased mortality among low-income adults, saving thousands of lives since 2010. The research highlights the importance of healthcare policy in improving survival rates.



